Rethinking Pulmonary Rehabilitation - a Three-arm Randomised Multicentre Trial

NCT05664945 | Active Not Recruiting

• 1 other identifier: H-22015777
• Study Type: interventional
• Target: 180
• Locations: 1 country
• Sites: 7

Brief Summary

Pulmonary rehabilitation (PR) is one of the cornerstones of care for people with COPD together with smoking cessation and medical treatment. Despite the compelling evidence for its benefits, pulmonary rehabilitation is delivered to less than 30% of patients with COPD. Access to PR are particularly challenging, and especially for those with the most progressed stages of the disease. Pulmonary Tele-rehabilitation (PTR) and Home-based pulmonary rehabilitation (HPR) are two emerging models using health-care supportive technology that have proven equivalent to the conventional PR programs in patients with COPD who are able and willing to participate in conventional PR. However, much remain unknown regarding patients with COPD unable to access and participate in the conventional out-patient hospital- or community-based PR when offered during routine consultation. No studies have been conducted to specifically intervene towards this group. Response from emerging rehabilitation models for this specific group is a black box with no substantial research. To fulfill its potential of relevance, results from emerging models, such as Pulmonary Telerehabilitation and Home-based pulmonary rehabilitation must be of clinical relevance, and superior to the current 'usual care' (medication and scheduled follow-up control) in patients with COPD unable to access and participate in the conventional out-patient hospital- or community-based PR when offered during routine consultation.

Conditions

Chronic Obstructive Pulmonary Disease

Outcome Measures

Primary Outcomes (1)

• Change in COPD Assessment Test (CAT)

  Patient completed questionnaires that assess respiratory symptoms. Eight item questionaire with total score from 0-40 points.

  Baseline; 10-weeks from baseline (primary endpoint); 35-weeks from baseline; 75-weeks from baseline (secondary endpoint)

Secondary Outcomes (14)

• Change in 1-minute sit-to-stand test (1-min-STS)

  Baseline; 10-weeks from baseline (primary endpoint); 35-weeks from baseline; 75-weeks from baseline (secondary endpoint)

• Change in 30seconds sit-to-stand test (30sec-STS)

  Baseline; 10-weeks from baseline (primary endpoint); 35-weeks from baseline; 75-weeks from baseline (secondary endpoint)

• Change in Short Physcial Performance Battery (SPPB)

  Baseline; 10-weeks from baseline (primary endpoint); 35-weeks from baseline; 75-weeks from baseline (secondary endpoint)

• Change in Handgrip strength (JAMAR)

  Baseline; 10-weeks from baseline (primary endpoint); 35-weeks from baseline; 75-weeks from baseline (secondary endpoint)

• Changes in objectively measured physical acitivity (50% of total sample)

  Baseline; 10-weeks from baseline ( primary endpoint); 35-weeks from baseline; 75-weeks from baseline (secondary endpoint)

Study Arms (3)

pulmonary tele-rehabilitation (PTR)

EXPERIMENTAL

Recieve supervised PTR 2/weekly, session duration of 60 min; 35 min of exercise and 25min of patient education for 10-weeks (primary endpoint). Delivered from Hvidovre/Bispebjerg Hospital to groups of 4-6 patients who exercise at home and communicate via tablet-camera. After 10-weeks of PTR, participants are offered once weekly PTR for 60minuttes in groups of 4-8 patients throughout a 65-week maintenance period (secondary endpoint 75-weeks from baseline).

Behavioral: pulmonary tele-rehabilitation (PTR)

home-based pulmonary rehabilitation (HPR)

EXPERIMENTAL

HPR is an individual self-initiated home-based PR program. Patient goal is to achieve at least 20 min of self-initiated muscle-endurance based exercise 3days/weekly for 10-weeks (primary endpoint). The first session is a home visit by an experienced respiratory physiotherapist and with focus on establishment of exercise goals, formal exercise prescription and education. The home visit is followed by 1/weekly session for 10-weeks.The sessions is delivered from Hvidovre/Bispebjerg Hospital via tablet-camera or telephone call. After 10-weeks of HPR, participants are offered once weekly PTR for 60min in groups of 4-8 patients throughout a 65-week maintenance period (secondary endpoint 75-weeks from baseline).

Behavioral: home-based pulmonary rehabilitation (HPR)

Control

ACTIVE COMPARATOR

Control group will receive usual care; medication, scheduled follow-up visit and possible phone contact with GP or the outpatient respiratory department. Except for assessment visits 10-, 35-, and 75-weeks from baseline no intervention is offered.

Behavioral: Control

Interventions

pulmonary tele-rehabilitation (PTR) BEHAVIORAL

PTR is delivered from promoter hospital to a group of 4-6 patients who exercise at home and communicate via tablet-camera. Each session is 60 min; 35 min exercise/ 25 min patient education, two times per week for a duration of 10-weeks (primary endpoint). Specific exercises are evidence-based; been used in several intervention studies on patients with COPD. Exercises involves larger muscle groups with 50/50 exercises for upper and lower extremities. Volume, intensity and content exercise protocol follow both national and international exercise recommendations. The education sessions consist of dialogue, reflections around empowerment and better living with COPD. Every fourth education session consists of 25 min Mindfulness exercises developed for COPD patients. After 10-weeks of PTR, participants are offered once weekly PTR for 60min in groups of 4-8 persons throughout a 65-week maintenance period (secondary endpoint 75-weeks from baseline).

pulmonary tele-rehabilitation (PTR)

home-based pulmonary rehabilitation (HPR) BEHAVIORAL

HPR is an individual self-initiated home-based PR aiming to achieve 20 min of self-initiated muscle-endurance based exercise; 3-days/weekly for 10-weeks (primary endpoint). Exercises are evidence-based; used in several intervention studies on patients with COPD and involves larger muscle groups with 50/50 exercises for upper/lower extremities. First session is a home visit by a respiratory physiotherapist. During the visit the physiotherapist and patient establish exercise goals, exercise prescription and provision of mindfulness exercises and educationbook. The home visit is followed by one weekly session for 10-weeks. A menu of topics relevant to COPD and self-management is discussed. A session is delivered from promoter hospital via tablet-camera or telephone call (patients' preference). After 10-weeks of HPR, participants are offered once weekly PTR for 60min in groups of 4-8 persons throughout a 65-week maintenance period (secondary endpoint 75-weeks from baseline).

home-based pulmonary rehabilitation (HPR)

Control BEHAVIORAL

Receive usual care; medication, scheduled follow-up visit and possible phone contact with GP and the outpatient respiratory department. Except for assessment visits 10-, 35-, and 75-weeks from baseline no intervention is offered. If a patient changes his/her mind and wishes to participate in a conventional hospital- or community-based PR program, it will be granted as this is a highly recommended treatment (e.g. rehabilitation after hospital admitted exacerbation).

Control

Eligibility Criteria

• Age: 40 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Indication for pulmonary rehabilitation according to Danish national guidelines
• Unable to access and participate in the conventional out-patient hospital- or community-based PR when offered during routine consultation
• A post-bronchodilator ratio FEV1/FVC \<70% (confirmed physician diagnosis of COPD)
• A post-bronchodilator FEV1 \<80% (degree of airway obstruction) corresponding to GOLD grade 2-4 (moderate to very severe)
• GOLD group B, C, D corresponding to severe respiratory symptoms and/or frequent acute exacerbations
• Able to stand up from a chair (height 44-46cm) and walk 10 meters independently (with or without a walking aid)
• Able to lift both arms to a horizontal level with a minimum of 1 kilogram's dumbbells in each hand

You may not qualify if:

• Participation in conventional PR in the past 24 months
• Cognitive impairment - unable to follow instructions
• Impaired hearing or vision - unable to see or hear instruction from a tablet
• Unable to understand and speak Danish
• Comorbidities where the exercise content is contraindicated (e.g. treatment for diabetic foot ulcer, active cancer treatment, life expectancy \<12-months)

Sponsors & Collaborators

• University Hospital Bispebjerg and Frederiksberg: collaborator
• Copenhagen University Hospital, Hvidovre: lead
• Hillerod Hospital, Denmark: collaborator
• Herlev and Gentofte Hospital: collaborator

Study Sites (7)

Copenhagen University Hospital Amager

Copenhagen, Greater Copenhagen, 2300, Denmark

Location

Copenhagen University Hospital Bispebjerg-Frederiksberg

Copenhagen, Greater Copenhagen, 2400, Denmark

Location

Copenhagen University Hospital Herlve-Gentofte

Gentofte Municipality, Greater Copenhagen, 2820, Denmark

Location

Copenhagen University Hospital Nordsjaelland

Hillerød, Greater Copenhagen, 3400, Denmark

Location

Copenhagen University Hospital Hvidovre

Hvidovre, Greater Copenhagen, 2650, Denmark

Location

Municipality of Copenhagen

Copenhagen, 2100, Denmark

Location

Bornholms Hospital

Rønne, 3700, Denmark

Location

Related Publications (1)

• Nielsen C, Godtfredsen N, Molsted S, Ulrik C, Kallemose T, Hansen H. Supervised pulmonary tele-rehabilitation and individualized home-based pulmonary rehabilitation for patients with COPD, unable to participate in center-based programs. The protocol for a multicenter randomized controlled trial - the REPORT study. PLoS One. 2025 Jan 7;20(1):e0312742. doi: 10.1371/journal.pone.0312742. eCollection 2025.

  PMID: 39774509 BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Henrik Hansen, PhD

  Dept. of Respiratory Medicine, University Hospital Hvidovre

  PRINCIPAL INVESTIGATOR

• Nina Godtfredsen, MD, PhD

  Dept. of Respiratory Medicine, University Hospital Hvidovre

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Masking Details: Participants will be informed that the trial is assessing the impact of pulmonary rehabilitation models on predetermined outcomes, but not the specific nature of the models of interest, and the predetermined hypothesis of the intervention group allocated to. All assessors are blinded to group allocation and previous test results. In case of failure keeping the outcome assessor blinded (that is, if a participant reveals his/her allocation) a second assessor will be available to step in and conduct the assessment on another day. To avoid investigators (subconscious) bias the biostatistician who perform the data analyses and validate the results is blinded to group allocation. The research group will interpret the results, before the allocation code is broken.
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: A randomized clinical, assessor- and statistician blinded multicentre trial with three parallel-groups

Study Record Dates

• First Submitted: December 9, 2022
• First Posted: December 27, 2022
• Study Start: January 10, 2023
• Primary Completion: October 7, 2025
• Study Completion (Estimated): July 31, 2027
• Last Updated: March 6, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

DK (7)